Should Moderna Before Aug.: A Clear Investor Guide for 2026
As Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
Need immediate cash? Explore where to sell things for immediate cash and get the funds you need right away.
20,928 articlesAs Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
SpaceX shares have tumbled from their peak, trading around $125 as of mid-July 2026. Analysts debate whether the retr...
GLAD faces a delicate turning point as the Fed freezes rates, pressuring yields on its floating-rate loans while port...
Thomson Reuters stock crushed expectations on Monday as AI announcements sparked momentum. This guide breaks down wha...
Markets swing and fear spreads fast. This guide breaks down what happens your investments in a crash, how different a...
Ohio is poised to boost its innovation engine. By conforming to the federal R&E immediate cost recovery rules, oh...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
BioNTech’s stock is under pressure as investors react to weak guidance and leadership pivots. This deep dive breaks d...
A major fund exits a Buckle stake, triggering questions about strategy and market signals. This article breaks down w...
An executive sale of shares often sparks questions. This article unpacks what cheesecake factory sells $328000 means ...
Strategy, led by Michael Saylor, plans to fund STRC dividends by selling Bitcoin, with a long-term goal to buy more B...
The market has sprinted higher, and valuations feel stretched. History, however, shows that corrections are a normal ...